The other ‘C’: hospital-acquired clostridioides difficile infection during the coronavirus disease 2019 (COVID-19) pandemic

Hazel, Karl; Skally, Mairead; Glynn, Emily; Foley, Margaret; Burns, Karen; O'Toole, Aoibhlinn; Boland, Karen; Fitzpatrick, Fidelma

the-other-c-hospital-acquired-clostridioides-difficile-infection-during-the-coronavirus-disease-2019-covid-19-pandemic.pdf (244.08 kB)

Download file

The other ‘C’: hospital-acquired clostridioides difficile infection during the coronavirus disease 2019 (COVID-19) pandemic

journal contribution

posted on 15.02.2022, 10:13 by Karl HazelKarl Hazel, Mairead Skally, Emily Glynn, Margaret Foley, Karen BurnsKaren Burns, Aoibhlinn O'TooleAoibhlinn O'Toole, Karen BolandKaren Boland, Fidelma FitzpatrickFidelma Fitzpatrick

We read with interest the recent article by LeRose et al on the impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infection. In contrast to their observations of increased central-line–associated infection and blood-culture contamination rates during the first wave of the COVID-19 pandemic, we observed a decrease in hospital-acquired Clostridioides difficile infection (HA-CDI) within our institution over this time, compared with the same period in previous years.

History

References

https://pubmed.ncbi.nlm.nih.gov/33436112/

Comments

The original article is available at https://www.cambridge.org/

Published Citation

Hazel K, et al. The other 'C': hospital-acquired clostridioides difficile infection during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021:1-2